Determination of the initial DNA damage and residual DNA damage remaining after 12 hours of repair in eleven cell lines at low doses of irradiation

By Roos W. P.   Binder A.   Böhm L.  

International Journal of Radiation Biology, Vol. 76, Iss. 11, 2000-11 ,pp. : 1493-1500

Informa Healthcare

Access to resources Recommend Favorite

Myocardial Function in Children and Adolescents after Therapy with Anthracyclines and Chest Irradiation

By Pihkala J.   Saarinen U.M.   Lundstrom U.   Virtanen K.   Virkola K.   Siimes M.A.   Pesonen E.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 97-103

Elsevier

Access to resources Recommend Favorite

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

By Hartmann M.   Fedders M.   Schneider A.   Kath R.   Camara O.   Oelschläger H.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 619-625

Springer Publishing Company

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

How Shall We Name the Chemotherapy Administration Before and After Metastasectomy? How About “M-Neoadjuvant” and “M-Adjuvant”?

By Abalı Hüseyin  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1970-1970

Springer Publishing Company

Access to resources Recommend Favorite